Chlamydia ascites: a call for sexually transmitted infection testing

BMJ Case Rep. 2018 Dec 22;11(1):e226437. doi: 10.1136/bcr-2018-226437.

Abstract

A 26-year-old gravida 2, para 2-0-0-2 woman with a recent uncomplicated vaginal delivery 10 weeks prior presented to our hospital with 5 weeks of abdominal swelling and discomfort. Four weeks after delivery, the patient began having right upper quadrant pain and was found to have cholelithiasis. She underwent an elective laparoscopic cholecystectomy 6 weeks prior to admission, but started to develop worsening abdominal swelling 1 week postoperatively. Abdominal distension and shifting dullness were present on examination. CT of the abdomen and pelvis was remarkable for moderate-volume ascites and mild enhancement of the pelvic peritoneum. Paracentesis removed 2.46 L of ascites fluid with 76% lymphocytic predominance. Results for Chlamydia trachomatis were positive in urine, cervical swab and ascitic fluid. Doxycycline was prescribed for a diagnosis of pelvic inflammatory disease exudative ascites. Since discharge, she has completed her antibiotic course and reports resolution of all symptoms without recurrence of ascites.

Keywords: general practice / family medicine; infection (gastroenterology); infectious diseases; obstetrics and gynaecology.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Ascites / drug therapy
  • Ascites / microbiology*
  • Chlamydia Infections / drug therapy
  • Chlamydia Infections / microbiology*
  • Chlamydia trachomatis / isolation & purification*
  • Doxycycline / therapeutic use
  • Female
  • Humans
  • Pelvic Inflammatory Disease / drug therapy
  • Pelvic Inflammatory Disease / microbiology*
  • Pregnancy
  • Puerperal Infection / drug therapy
  • Puerperal Infection / microbiology*

Substances

  • Anti-Bacterial Agents
  • Doxycycline